Congressman Invests in Lesser-Known Small Cap Lift Truck Firm
Congressman's Stock Transactions: Rep. Tim Moore (R-N.C.) disclosed multiple stock purchases, including significant investments in Hyster-Yale Inc., totaling between $145,000 and $350,000, which has attracted social media attention.
Recent Trading Activity: Moore's recent trades included buying shares of Hyster-Yale on several occasions in November, following previous transactions in October and September, with no sales reported this time.
Market Impact: Following the news of Moore's purchases, Hyster-Yale's stock price surged from $28.12 to $35.03, raising questions about the implications of his trades, especially given the company's history with government contracts.
Additional Investments: Alongside Hyster-Yale, Moore also purchased shares in Genprex, a small clinical stage gene therapy company, marking one of the smallest stocks ever bought by a member of Congress, which is expected to draw further scrutiny.
Trade with 70% Backtested Accuracy
Analyst Views on HY
About HY
About the author

- EPS Revision Analysis: As the earnings season approaches, several mid to low-cap industrial stocks have received an 'F' grade for earnings momentum, indicating significant downward pressure on analyst expectations for future earnings.
- Affected Companies: Companies such as Alight (ALIT), Alaska Air Group (ALK), and Apogee Enterprises (APOG) have all received an 'F' grade, highlighting severe challenges to their earnings outlook.
- Market Reaction Expectations: These companies may face cautious investor sentiment due to factors like heavy debt and high customer churn rates, which could negatively impact their stock performance.
- Industry Outlook: Despite the current poor EPS revision grades, the market remains optimistic about the industrial sector's prospects for 2026, potentially providing support for future investment opportunities.
- Congressional Trading Performance: According to Quiver Quantitative, Tim Moore topped the list of congressional traders in 2025 with a 52% gain, showcasing successful investment strategies in small caps and Cracker Barrel stock, which may attract more investor attention to his future trades.
- Pelosi's Earnings Situation: Despite Nancy Pelosi achieving an 18% gain in 2025, she failed to make the top ten, reflecting her underperformance relative to the market average, which could impact her reputation among investors.
- Transparency Issues in Trading: As members of Congress remain active in trading stocks, options, and cryptocurrencies, public scrutiny over their trading transparency is increasing, especially with high-profile figures like Greene and Pelosi no longer required to disclose their investments, potentially sparking greater controversy.
- Market Trend Observation: In 2025, the SPDR S&P 500 ETF Trust rose by 16.6%, while congressional members generally outperformed the market, indicating their advantages in investment decisions and possibly prompting calls for stricter trading regulations for legislators.
- Leadership Appointment: Mativ announced the appointment of Scott Minder as Chief Financial Officer effective January 1, 2026, succeeding Greg Weitzel, who will remain until December 31, 2025, ensuring a smooth transition.
- Extensive Experience: With over 30 years of financial leadership, Minder has successfully executed financial turnarounds at companies like Hyster-Yale, significantly reducing leverage and enhancing profitability, laying a solid foundation for Mativ's future.
- Strategic Alignment: Mativ's CEO, Shruti Singhal, highlighted that Minder's financial expertise will help strengthen the balance sheet and enhance commercial execution, accelerating profitable growth and increasing shareholder value.
- Transformational Opportunity: Minder expressed excitement about Mativ's turnaround efforts and looks forward to providing financial leadership during the company's next growth phase, further driving success in a complex market environment.
Appointment of CFO: Mativ Holdings, Inc. has appointed Scott Minder as Chief Financial Officer, effective January 1, 2026, succeeding Greg Weitzel, who will remain until the end of 2025.
Minder's Experience: Scott Minder brings over 30 years of financial leadership experience, having previously served as CFO at Hyster-Yale, Inc. and held roles at ATI, PPG Industries, Penske Logistics, and General Motors.
Company's Strategic Goals: Mativ's President and CEO, Shruti Singhal, expressed confidence in Minder's ability to enhance financial performance and drive profitable growth as the company focuses on strengthening its balance sheet.
Mativ's Operations: Mativ Holdings is a global leader in specialty materials, operating across three continents and generating sales in over 80 countries, with a focus on innovative solutions in filtration, advanced materials, and sustainable adhesive solutions.

Activist Investor Involvement: Elliott Investment Management is engaging with Toyota Motor and another Japanese company sharing the Toyota name, indicating potential investment strategies.
Market Opportunities: The stock market presents unique situations that could lead to profitable investment opportunities, particularly in the context of the ongoing developments involving these companies.
Congressman's Stock Transactions: Rep. Tim Moore (R-N.C.) disclosed multiple stock purchases, including significant investments in Hyster-Yale Inc., totaling between $145,000 and $350,000, which has attracted social media attention.
Recent Trading Activity: Moore's recent trades included buying shares of Hyster-Yale on several occasions in November, following previous transactions in October and September, with no sales reported this time.
Market Impact: Following the news of Moore's purchases, Hyster-Yale's stock price surged from $28.12 to $35.03, raising questions about the implications of his trades, especially given the company's history with government contracts.
Additional Investments: Alongside Hyster-Yale, Moore also purchased shares in Genprex, a small clinical stage gene therapy company, marking one of the smallest stocks ever bought by a member of Congress, which is expected to draw further scrutiny.










